Valeant Pharmaceuticals International (Montreal, Quebec) has agreed to shell out nearly $14.5 billion to acquire Salix Pharmaceuticals (Raleigh, North Carolina). Salix makes medical devices as well as pharmaceutical products for the prevention and treatment of gastrointestinal diseases.
